The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Progesterone as a Bone-Trophic Hormone
Abstract
Experimental, epidemiological, and clinical data indicate that progesterone is active in bone metabolism. Progesterone appears to act directly on bone by engaging an osteoblast receptor or indirectly through competition for a glucocorticoid osteoblast receptor. Progesterone seems to promote bone formation and/or increase bone turnover. It is possible, through estrogen-stimulated increased progesterone binding to the osteoblast receptor, that progesterone plays a role in the coupling of bone resorption with bone formation. A model of the interdependent actions of progesterone and estrogen on appropriately-"ready" cells in each bone multicellular unit can be tied into the integrated secretions of these hormones within the ovulatory cycle. Figure 5 is an illustration of this concept. It shows the phases of the bone remodeling cycle in parallel with temporal changes in gonadal steroids across a stylized ovulatory cycle. Increasing estrogen production before ovulation may reverse the resorption occurring in a "sensitive" bone multicellular unit while gonadal steroid levels are low at the time of menstrual flow. The bone remodeling unit would then be ready to begin a phase of formation as progesterone levels peaked in the midluteal phase. From this perspective, the normal ovulatory cycle looks like a natural bone-activating, coherence cycle. Critical analysis of the reviewed data indicate that progesterone meets the necessary criteria to play a causal role in mineral metabolism. This review provides the preliminary basis for further molecular, genetic, experimental, and clinical investigation of the role(s) of progesterone in bone remodeling. Much further data are needed about the interrelationships between gonadal steroids and the "life cycle" of bone. Feldman et al., however, may have been prophetic when he commented; "If this anti-glucocorticoid effect of progesterone also holds true in bone, then postmenopausal osteoporosis may be, in part, a progesterone deficiency disease."
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Evidence of Estrogen Receptors in Normal Human Osteoblast-Like Cells
Eriksen, E. F., Colvard, D. S., Berg, N. J., Graham, M. L., Mann, K. G., Spelsberg, T. C., & Riggs, B. L. (1988) · Science · doi:10.1126/science.3388021 · Cited by 1,229
Tetracycline-based histological analysis of bone remodeling
Frost, H. M. (1969) · Calcified Tissue Research · doi:10.1007/bf02058664 · Cited by 1,111
POSTMENOPAUSAL OSTEOPOROSIS: ITS CLINICAL FEATURES
ALBRIGHT, F., SMITH, P. H., & RICHARDSON, A. M. (1941) · Journal of the American Medical Association · doi:10.1001/jama.1941.02820220007002 · Cited by 829
Estrogen Binding, Receptor mRNA, and Biologic Response in Osteoblast-Like Osteosarcoma Cells
Komm, B. S., Terpening, C. M., Benz, D. J., Graeme, K. A., Gallegos, A., Korc, M., Greene, G. L., O'Malley, B. W., & Haussler, M. R. (1988) · Science · doi:10.1126/science.3164526 · Cited by 812
Decreased Risk of Fractures of the Hip and Lower Forearm with Postmenopausal Use of Estrogen
Weiss, N. S., Ure, C. L., Ballard, J. H., Williams, A. R., & Daling, J. R. (1980) · New England Journal of Medicine · doi:10.1056/nejm198011203032102 · Cited by 775
Hip Fracture and the Use of Estrogens in Postmenopausal Women: The Framingham Study
KIEL, D. P., FELSON, D. T., ANDERSON, J. J., WILSON, P. W. F., & MOSKOWITZ, M. A. (1988) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198807000-00018 · Cited by 625
Growth factors and the regulation of bone remodeling.
Canalis, E., McCarthy, T., & Centrella, M. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113318 · Cited by 602
BONE MASS IN POSTMENOPAUSAL WOMEN AFTER WITHDRAWAL OF OESTROGEN/GESTAGEN REPLACEMENT THERAPY
Christiansen, C., Sanvig Christensen, M., & Transbøl, I. (1981) · The Lancet · doi:10.1016/s0140-6736(81)91848-1 · Cited by 593
Postmenopausal Bone Loss Is Prevented by Treatment with Low-Dosage Estrogen with Calcium
ETTINGER, B., GENANT, H. K., & CANN, C. E. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-1-40 · Cited by 531
Dewhirst, F. E., Stashenko, P. P., Mole, J. E., & Tsurumachi, T. (1985) · The Journal of Immunology · doi:10.4049/jimmunol.135.4.2562 · Cited by 507
Cited by
Physiological Action of Progesterone in Target Tissues*
Graham, J. D., & Clarke, C. L. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.4.0308 · Cited by 1,008
Changes in Proinflammatory Cytokine Activity after Menopause
Pfeilschifter, J., Köditz, R., Pfohl, M., & Schatz, H. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.1.0456 · Cited by 914
Megestrol acetate for the prevention of hot flashes.
Loprinzi, C. L., Michalak, J. C., Quella, S. K., O'Fallon, J. R., Hatfield, A. K., Nelimark, R. A., Dose, A. M., Fischer, T., Johnson, C., Klatt, N. E., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408113310602 · Cited by 500
Spinal Bone Loss and Ovulatory Disturbances
Prior, J. C., Vigna, Y. M., Schechter, M. T., & Burgess, A. E. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011013231801 · Cited by 454
Self-citationRegulation of Bone Metabolism by Sex Steroids
Khosla, S., & Monroe, D. G. (2018) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a031211 · Cited by 323
Metadata
- Authors
- PRIOR, J. C.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 1990-05
- Volume
- 11
- Issue
- 2
- Pages
- 386-398
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2154697918
- Cited by
- 273
- References
- 57
- FWCI
- 4.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Progesterone as a Bone-Trophic Hormone. https://app.cochat.ai/papers/10.1210/edrv-11-2-386
- The paper
- PRIOR, J. C. (1990). Progesterone as a Bone-Trophic Hormone. Endocrine Reviews. https://doi.org/10.1210/edrv-11-2-386
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.